UT Health Science Center at San Antonio, School of Dentistry
San Antonio, Texas, 78229, United States
NCT Number: NCT02515058
The study is a 2-arm, parallel-design, randomized, prospective clinical trial designed to examine histologic wound healing following ridge preservation using bone allograft that has been prepared by either freeze-drying or via a non-freeze-dried solvent process.This entire protocol involves procedures that are standard care. All materials are FDA-approved materials being used in an FDA-approved manner. The test group subjects will have extraction sockets grafted with a cancellous non-freeze-dried bone allograft (called PUROS graft). This test group will be compared to an active control group using cancellous freeze-dried bone allograft (called FDBA). The null hypothesis is that there will be no significant difference in formation of new vital bone between treatment groups (primary outcome).
Each subject will provide a single non-molar tooth site for study treatment. After tooth extraction, the graft material will be placed and covered by a resorbable collagen membrane. Following 3 months of healing, the dental implant will be place, at which time a core of bone will be removed from the site as part of the preparation for the implant. The core biopsy will then be evaluated for the primary histologic outcome of % vital bone formation and secondary histologic outcome of % residual graft material.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Interventional
Not applicable
San Antonio, Texas, 78229, United States
The study is designed to examine histologic wound healing following ridge preservation using cancellous bone allograft that has been prepared either by freeze-drying (FDBA) or by a solvent-based processing method (PUROS). This entire protocol involves procedures that are standard care. All materials are FDA-approved materials being used in an FDA-approved manner. The test group subjects will have extraction sockets grafted with a cancellous non-freeze-dried bone allograft (called PUROS graft). This test group will be compared to an active control group using cancellous freeze-dried bone allograft (called FDBA). The null hypothesis is that there will be no significant difference in formation of new vital bone between treatment groups (primary outcome).
Each subject will provide a single non-molar tooth site for study treatment. After tooth extraction, the graft material will be placed and covered by a resorbable collagen membrane. Following 3 months of healing, the dental implant will be place, at which time a core of bone will be removed from the site as part of the preparation for the implant. The core biopsy will then be evaluated for the primary histologic outcome of % vital bone formation and secondary histologic outcome of % residual graft material.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients will be included in this study if they qualify the following inclusion criteria:
Exclusion criteria
Ridge preservation bone grafting after tooth extraction
Ridge preservation bone grafting after tooth extraction
Time frame: 3 months after ridge preservation
histologic determination of % of vital bone formation
Time frame: 3 months after ridge preservation
histologic determination of % of residual bone graft material
The University of Texas Health Science Center at San Antonio
Other
Ridge Preservation Following Tooth Extraction Using Mineralized Freeze-Dried Bone Allograft Compared to PUROS Mineralized Bone Allograft
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07716007
Alveolar Bone Loss, Behavior
Cairo, Egypt
View Trial DetailsNCT06887595
Alveolar Bone Loss, Bone Diseases
Kafr ash Shaykh, Kafrelsheikh, Egypt
View Trial DetailsNCT07665281
Alveolar Bone Loss, Bone Diseases
Hillah, Babylon, Iraq
View Trial DetailsNCT07654218
Alveolar Bone Loss, Alveolar Ridge Deficiency
Porto, Portugal
View Trial Details